BeGenius: Broad Assay Portfolio Announced
Bruker announced major advancements at ESCMID Global, including expanded PCR assay options for its BeGenius system.
Bruker announced major advancements at ESCMID Global, including expanded PCR assay options for its BeGenius system.
Two studies demonstrate the potential of a genomic screening platform to improve early detection of genetic diseases in newborns.
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
A new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read MoreFoundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.Â
Read MoreJona announced a new distribution partnership where practitioners can order Jona kits, the company’s AI-powered gut microbiome profile test.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreThe collaboration seeks to demonstrate the value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
Read MoreResearchers developed a platform for integrating DNA and RNA data from single-cell sequencing with improved speed and precision.
Read MoreResearchers analyzed data from children who suffered from syndromic conditions and found a high incidence of overlapping genetic alterations.
Read MoreThe new suite of high-quality adapters, universal blockers, and library amplification primer mixes are designed for the AVITI System.
Read MoreThe system features full 24/7 run automation, flexibility for smaller and faster runs, high accuracy for germline applications, and more.
Read MoreFindings from NGS suggest that revising cancer care guidelines could allow many more patients to benefit from immunotherapy treatment.
Read MoreGenomenon, a genomic intelligence company, has launched Genomenon Curate-Pro, a rapid on-demand...
Read MoreIllumina’s Global Health Access Initiative will support access to pathogen sequencing tools for public health in lower income countries.
Read MoreSequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read MoreCentogene announced the expansion of MOx, the company’s multiomic diagnostic portfolio, now incorporating transcriptomic analysis.
Read MoreThe new NGS test detects gene fusions, translocations, and rearrangements across 361 genes from FFPE tumor tissue.Â
Read More